SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 33 filers reported holding SATSUMA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $125,000 | – | 8,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,681,858 | $21,583,000 | 0.30% |
| Ghost Tree Capital, LLC | 200,000 | $922,000 | 0.20% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,694,000 | 0.10% |
| PDT Partners, LLC | 67,100 | $309,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 13,908 | $64,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 195,651 | $902,000 | 0.01% |
| WEXFORD CAPITAL LP | 8,365 | $39,000 | 0.01% |
| Virtu Financial LLC | 10,133 | $47,000 | 0.01% |
| WINTON GROUP Ltd | 11,911 | $55,000 | 0.00% |
| Engineers Gate Manager LP | 13,678 | $63,000 | 0.00% |